426.88
0.85%
+3.59
After Hours:
425.79
-1.09
-0.26%
Atrion Corp. stock is currently priced at $426.88, with a 24-hour trading volume of 36,882.
It has seen a +0.85% increased in the last 24 hours and a +4.42% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $421.6 pivot point. If it approaches the $429.2 resistance level, significant changes may occur.
Previous Close:
$423.29
Open:
$417.01
24h Volume:
36,882
Market Cap:
$751.24M
Revenue:
$169.33M
Net Income/Loss:
$19.41M
P/E Ratio:
27.81
EPS:
15.35
Net Cash Flow:
$-2.31M
1W Performance:
+0.63%
1M Performance:
+4.42%
6M Performance:
+28.46%
1Y Performance:
-30.81%
Atrion Corp. Stock (ATRI) Company Profile
Name
Atrion Corp.
Sector
Industry
Phone
972-390-9800
Address
One Allentown Parkway, Allen, TX
Atrion Corp. Stock (ATRI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-25-16 | Initiated | BWS Financial | Sell |
Atrion Corp. Stock (ATRI) Latest News
Atrion Reports Fourth Quarter And Full Year 2023 Results
GlobeNewswire Inc.
Atrion Corporation Declares Quarterly Cash Dividend
GlobeNewswire Inc.
Top 3 Health Care Stocks That May Plunge In January
Benzinga
Dividend Champion, Contender, And Challenger Highlights: Week Of November 26
Seeking Alpha
Atrion Corporation Declares Quarterly Cash Dividend
GlobeNewswire Inc.
Atrion Reports Third Quarter 2023 Results
GlobeNewswire Inc.
Atrion Corp. Stock (ATRI) Financials Data
Atrion Corp. (ATRI) Revenue 2024
ATRI reported a revenue (TTM) of $169.33 million for the quarter ending December 31, 2023, a -7.73% decline year-over-year.
Atrion Corp. (ATRI) Net Income 2024
ATRI net income (TTM) was $19.41 million for the quarter ending December 31, 2023, a -44.55% decrease year-over-year.
Atrion Corp. (ATRI) Cash Flow 2024
ATRI recorded a free cash flow (TTM) of -$2.31 million for the quarter ending December 31, 2023, a +53.24% increase year-over-year.
Atrion Corp. (ATRI) Earnings per Share 2024
ATRI earnings per share (TTM) was $11.02 for the quarter ending December 31, 2023, a -43.63% decline year-over-year.
About Atrion Corp.
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 myocardial protection system that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers, as well as other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Cap:
|
Volume (24h):